App Note: What dose-response and orthogonal assays revealed about MEK1 screening
Posted in News
|A new App Note is now available to download from Nanotemper.
This study highlights the Dianthus uHTS platform for biophysical screening of MEK1, a key kinase in the MAPK/ERK pathway. Using Spectral Shift technology, ~5,120 compounds were profiled in single-dose mode, generating ~250,000 data points per day.
Download the Application Note to learn more about:
- Ultra-high-throughput biophysical screening enabled by Spectral Shift technology
- Rapid identification of high-affinity hits from large compound libraries
- A low sample consumption biophysical method with broad applicability across diverse target classes
